Model-Informed Generics Copilot

Model-informed generic development support for reference-product analysis, patent context, excipients, and launch questions.

Reverse Engineering Paragraph IV Strategy Patent Expiry Excipient Database

Innovator Reverse Engineering

Enter a drug name to see reverse-engineered formulation

Patent & Generic Opportunity

Patent expiry and opportunity assessment

FDA Excipient Database

FDA approved excipient ranges

First Generic & 180-day Exclusivity

First generic applicant and exclusivity period

Cost & Time Savings Analysis

Estimated savings from model-informed planning versus traditional development